Insiders who reported open-market trades in the last 12 months at the companies Aby J. Mathew files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Aby J. Mathew is a corporate insider, tracked as EVP & Chief Scientific Officer of BIOLIFE SOLUTIONS INC (BLFS). InsiderAlpha holds 21 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Aby J. Mathew submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Aby J. Mathew been buying or selling stock?
Recorded transactions: 0 open-market purchases and 16 open-market sales ($2.02M) across all tracked filings.
Aby J. Mathew is EVP & Chief Scientific Officer of BIOLIFE SOLUTIONS INC (BLFS). 21 SEC Form 4 filings on record going back to 2024, most recently on 9 October 2026. Most recent open-market trade: sold $11K of BLFS on 5 March 2026. Lifetime open-market sales: $2.02M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Aby J. Mathew.
InsiderAlpha's records for Aby J. Mathew go back to 2024: 21 primary Form 4 filings, an average of 7.0 per year. 19 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
